Boston Scientific acquires UK medical device company BTG in $4.2bn deal
Executive Summary
Boston Scientific Corp. agreed to acquire BTG plc (minimally invasive medical devices) for 840 pence per share ($10.76; 38% premium to the prior 10-day trading average) in cash or a total of £3.3bn ($4.2bn; enterprise value of $3.9bn).
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Site Specific
-
Drug Delivery
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice